Role of biomarkers in diagnostics, stratification of risk and prognosis of heart failure.
Open Access
- 24 May 2018
- journal article
- research article
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 23 (2(part1)), 56-63
- https://doi.org/10.26641/2307-0404.2018.2(part1).129517
Abstract
Heart failure occupies one of the leading places in the structure of the causes of adult mortality in the world. The issues of timely diagnosis and prognosis of the outcomes of this disease do not lose their relevance due to the high heterogeneity of clinical manifestations and absence of absolutely pathognomonic symptoms. The development of the multimarker diagnostic strategy for management of patients with heart failure is a progressive approach .The review focuses on the synthesis of known evidence data on the role of biomarkers in diagnostics and risk stratification.This publication has 27 references indexed in Scilit:
- Natriuretic Peptide-Guided Therapy in Chronic Heart Failure: A Meta-Analysis of 2,686 Patients in 12 Randomized TrialsPLOS ONE, 2013
- Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart FailureCirculation: Heart Failure, 2013
- Serial Measurement of Cardiac Troponin T Using a Highly Sensitive Assay in Patients With Chronic Heart FailureCirculation, 2012
- Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failureHeart, 2011
- Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term OutcomesCirculation: Heart Failure, 2011
- The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fractionEuropean Journal of Heart Failure, 2010
- Lowered B-Type Natriuretic Peptide in Response to Levosimendan or Dobutamine Treatment Is Associated With Improved Survival in Patients With Severe Acutely Decompensated Heart FailureJournal of the American College of Cardiology, 2009
- Amino-Terminal Pro–B-Type Natriuretic Peptides and Prognosis in Chronic Heart FailureThe American Journal of Cardiology, 2008
- The Seattle Heart Failure ModelCirculation, 2006
- The Transforming Growth Factor-β Superfamily Member Growth-Differentiation Factor-15 Protects the Heart From Ischemia/Reperfusion InjuryCirculation Research, 2006